Richard P. Burgoon
Corporate Officer/Principal bei The State Bar of California
Profil
Richard P.
Burgoon is the founder of Allon Therapeutics, Inc. (1994), Epiomed Therapeutics, Inc. (2010), and ChemNavigator.com, Inc. (1999).
At ChemNavigator.com, Inc., he held the title of Chairman from 1999 to 2011.
Currently, he is a Member of The State Bar of California.
Previously, he held positions such as Chief Executive Officer at Aeolus Pharmaceuticals, Inc., Senior Director at Cephalon, Inc., Director-Intellectual Property at IDEC Pharmaceuticals Corp., Staff Attorney at Beckman Instruments, Inc., SVP-Operations & General Counsel at Arena Pharmaceuticals, Inc., Secretary at Rebus Holdings, Inc., Partner at Xmark Fund Ltd., Associate at Lyon & Lyon, Inc., and President & Chief Operating Officer at Bitcoin Services, Inc. (2007-2015).
He holds an MBA from San Diego State University (2005), a graduate degree from Franklin Pierce College (1987), and an undergraduate degree from the University of California, Irvine (1984).
Aktive Positionen von Richard P. Burgoon
| Unternehmen | Position | Beginn |
|---|---|---|
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Richard P. Burgoon
| Unternehmen | Position | Ende |
|---|---|---|
| AEOLUS PHARMACEUTICALS, INC. | Präsident | 30.11.2006 |
| ALLON THERAPEUTICS INC. | Gründer | - |
Epiomed Therapeutics, Inc.
 Epiomed Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Epiomed Therapeutics, Inc. operates as a development stage pharmaceutical organization which focuses on the discovery, development and partnering of novel anti-emetic compounds for both the human and veterinary markets. The company was founded by David Reed Helton, Ernest H. Pfadenhauer and Richard P. Burgoon Jr. in October 2010 and is headquartered in Irvine, CA. | Gründer | - |
Lyon & Lyon, Inc.
 Lyon & Lyon, Inc. Miscellaneous Commercial ServicesCommercial Services Lyon & Lyon, Inc. engages in the provision of legal services. The company was founded on September 4, 1979 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| Xmark Fund Ltd. | Corporate Officer/Principal | - |
Ausbildung von Richard P. Burgoon
| San Diego State University | Masters Business Admin |
| Franklin Pierce College | Graduate Degree |
| University of California, Irvine | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AEOLUS PHARMACEUTICALS, INC. | Health Technology |
| REBUS HOLDINGS, INC. | Health Technology |
| ALLON THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Bitcoin Services, Inc.
 Bitcoin Services, Inc. Investment Banks/BrokersFinance Bitcoin Services, Inc. engages in the provision of bitcoin mining and blockchain software development. The company was founded on April 4, 1997 and is headquartered in Wilmington, DE. | Finance |
ChemNavigator.com, Inc.
 ChemNavigator.com, Inc. Packaged SoftwareTechnology Services ChemNavigator.com, Inc. provides cheminformatics product solutions for the management, analysis, and virtual screening of chemical databases. It provides medical related products and services for the researchers in medicinal, computational and synthetic chemistry industry. The company was founded by Tad Hurst and Scott Hutton in 1999 and is headquartered in Milwaukee, WI. | Technology Services |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
| Beckman Instruments, Inc. | Health Technology |
| Xmark Fund Ltd. | |
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Commercial Services |
Lyon & Lyon, Inc.
Lyon & Lyon, Inc. Miscellaneous Commercial ServicesCommercial Services Lyon & Lyon, Inc. engages in the provision of legal services. The company was founded on September 4, 1979 and is headquartered in San Diego, CA. | Commercial Services |
Epiomed Therapeutics, Inc.
Epiomed Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Epiomed Therapeutics, Inc. operates as a development stage pharmaceutical organization which focuses on the discovery, development and partnering of novel anti-emetic compounds for both the human and veterinary markets. The company was founded by David Reed Helton, Ernest H. Pfadenhauer and Richard P. Burgoon Jr. in October 2010 and is headquartered in Irvine, CA. | Health Technology |
